558
Participants
Start Date
February 28, 2014
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
Ibodutant 10 mg
Oral tablet, to be given once daily.
Placebo
Oral tablet (identical in appearance and weight to ibodutant tablets) to be given once daily.
Riga
Riga
Riga III
Budapest
Budapest
Vác
Debrecen
Debrecen
Valmiera
Mátészalka
Daugavpils
Gyula
Szekszárd
Pécs
New York
Berlin
Great Neck
Brooklyn
Berlin
Stockholm
Schwerin
Levittown
Columbia
Lund
Hamburg
Lynchburgh
Příbram
Winston-Salem
High Point
Staszów
Salisbury
Hickory
Anderson
Hanover
Hialeah
Miami Lakes
Hialeah
Miami Lakes
Miami
Miami
Miami
Miami
Miami
Lauderdale Lakes
Tamarac
Tampa
Pinellas Park
Fort Myers
Inverness
Kissimmee
České Budějovice
Kingsport
Germantown
Jackson
Katowice
Gothenburg
Mentor
Bochum
Franklin
Cincinnati
Evansville
Wyoming
Kralove
Clive
Wroclaw
Wroclaw
Mainz
Billings
Addison
Poznan
Oak Lawn
Frankfurt
Rockford
Poznan
St Louis
Shawnee
Metairie
Shreveport
North Little Rock
Little Rock
Little Rock
Uppsala
Zlín
Arlington
Karlsruhe
Houston
San Antonio
Centennial
Colorado Springs
Sopot
Bratislava
Bratislava
Sandy City
Logan
Ogden
Phoenix
Bratislava
Mesa
Chandler
Glendale
Lodz
Trenčín
Pasadena
Encino
North Hollywood
Trnava
San Diego
Laguna Hills
Orange
Nitra
Lincoln
Gold River
Seattle
Spokane
Brockton
Brockton
Newington
Kinston
Hradec Králové
Prague
Slaný
Leipzig
Budapest
Warsaw
Warsaw
Warsaw
Warsaw
Ilava
Bexhill-on-Sea
Chorley
Coventry
Edgbaston
Glasgow
Llanishen
North Manchester
Northumberland
Norwich
Reading
Waterloo
Lead Sponsor
Menarini Group
INDUSTRY